## **Core Concept**
Ciprofloxacin is a type of antibiotic known as a fluoroquinolone. It exerts its antibacterial effect by inhibiting bacterial DNA gyrase and topoisomerase IV, which are essential enzymes for DNA replication, transcription, repair, and recombination. This mechanism is critical for understanding its broad-spectrum antibacterial activity.

## **Why the Correct Answer is Right**
The correct answer, **DNA gyrase and topoisomerase IV**, is right because ciprofloxacin specifically targets these two enzymes in bacteria. DNA gyrase is crucial for bacterial DNA replication as it introduces negative supercoils into DNA, while topoisomerase IV is involved in the separation of intertwined DNA strands during replication and transcription. By inhibiting these enzymes, ciprofloxacin effectively prevents bacterial DNA replication, leading to bacterial cell death.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, although ciprofloxacin does affect bacterial cells, stating it acts on the "cell wall" is inaccurate. Ciprofloxacin's mechanism does not involve inhibiting cell wall synthesis like beta-lactam antibiotics (e.g., penicillins) or disrupting the cell membrane.
- **Option B:** This option is incorrect because ciprofloxacin does not primarily act on "protein synthesis." While some antibiotics, like tetracyclines and macrolides, inhibit protein synthesis by binding to bacterial ribosomal subunits, ciprofloxacin's action is focused on DNA replication.
- **Option D:** This option is incorrect because ciprofloxacin's action is not described as interfering with "metabolic pathways" in a general sense. Its mechanism is more specific, targeting DNA gyrase and topoisomerase IV.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that fluoroquinolones, such as ciprofloxacin, are known for their broad-spectrum activity but are particularly noted for their potential to cause **cartilage damage** in juvenile animals, leading to cautious use in pediatric populations. Additionally, they can have significant drug interactions and are not recommended in patients with certain conditions, such as uncontrolled hypertension.

## **Correct Answer:** C. DNA gyrase and topoisomerase IV.